*  Exposure Controls/Personal Protection  *
Respiratory Protection:WEAR APPROPRIATE NIOSH/MSHA APPROVED RESPIRATOR.
Ventilation:USE ONLY IN A CHEMICAL FUME HOOD.
Other Protective Equipment:WEAR SUITABLE PROTECTIVE CLOTHING. SAFETY
    SHOWER AND EYE BATH.
Work Hygienic Practices:READILY ABSORBED THROUGH SKIN. WASH THOROUGHLY
    AFTER HANDLING.
Supplemental Safety and Health
EFTS OF OVEREXP: POLYNEURITIS W/SEV PAIN IN LEGS & LOINS, PARTIAL
    PARALYSIS OF LEGS, ANGINA-LIKE PAINS, NEPHRITIS, WASTING & WEAK &
    LYMPHOCYTOSIS & EOSINOPHILIA. CHRONIC: OVEREXP MAY CAUSE REPRO
    DISOR DER(S) BASED ON TESTS W/LAB ANIMALS. TOTHE BEST OF MFR'S
    KNOWLEDGE, THE CHEM, PHYSICAL & TOXICOLOGICAL (ING 2)
*  Product Identification  *
*  Composition/Information on Ingredients  *
Ingred Name:THALLIUM (I) SULFATE (2:1); (THALLOUS SULFATE) (SARA
OSHA PEL:0.1 MG/M3, S
ACGIH TLV:0.1 MG/M3, S
Ingred Name:SUPDAT: PROPERTIES HAVE NOT BEEN THORO INVESTIGATED. IN
    CHRONIC POISONING, CENTRAL & PERIPHERAL NERVOUS SYSTEM (ING 3)
Ingred Name:ING 2: ABNORMALITIES MAY PERSIST INCLUDING ATAXIA, TREMOR,
    INCOORDINATION, PARALYSIS OF EXTREMITIES, ENDOCRINE (ING 4)
Ingred Name:ING 3: DISORDERS, MEMORY LOSS & PSYCHOSES MAY DEVELOP.
    TARGET ORGANS: NERVES, CVS, EYES, SKIN, LIVER, KIDNEYS, (ING 5)
Ingred Name:ING 4: MALE REPRODUCTIVE SYSTEM.
*  Hazards Identification  *
Routes of Entry: Inhalation:YES  Skin:YES  Ingestion:YES
Reports of Carcinogenicity:NTP:NO    IARC:NOOSHA:NO
Health Hazards Acute and Chronic:ACUTE: MAY BE FATAL IF
    INHALED/SWALLOWED/ABSORBED THRU SKIN. MAY CAUSE SKIN, EYE IRRIT.
    MAY BE IRRIT TO MUC MEMB & UPPER RESP TRACT. CAN CAUSE BLINDNESS.
    MOST CHARACT SYMP OF THALLIM EXPOS IS ALOPECIA  (LOSS OF HAIR).
    CUTANEOUS EFTS MAY INCL DRY, SCALY SKIN & IMPAIRMENT OF NAIL GROWTH
    OFTEN RSLTG IN (EFTS OF OVEREXP)
Explanation of Carcinogenicity:NOT RELEVANT
Effects of Overexposure:HLTH HAZ: APPEAR OF CRESCENT-SHAPED STRIPS
    ACROSS FINGERNAILS & TOENAILS (MEE'S LINE). OTHER SYMPS IN ACUTE
    POISONING RELATE CHIEFLY TO GI TRACT, NERVOUS SYS, SKIN, EYES &
    CVS. ACUTE POISONING RSLTS I N SWELL OF FEET & LEGS, ARTHRALGIA,
    VOMIT, INSOM, HYPERESTHESIA & PARESTHESIA OF HANDS & FEET, MENTAL
    CONFUSN, (SUPDAT)
Medical Cond Aggravated by Exposure:NONE SPECIFIED BY MANUFACTURER.
*  First Aid Measures  *
First Aid:EYES/SKIN: IMMED FLUSH EYES OR SKIN W/COPIOUS AMOUNTS OF
    INHAL: REMOVE TO FRESH AIR. IF NOT BREATHING GIVE ARTF RESP. IF
    BREATHING I S DIFFICULT, GIVE OXYGEN. INGEST: WASH OUT MOUTH
    W/WATER PROVIDED PERSON IS CONSCIOUS. CALL MD IMMED. WASH CONTAMD
    CLTHG BEFORE REUSE. FOR THALLIUM ANTIDOTE, SEE EUR. J. PHARMACOL.,
*  Fire Fighting Measures  *
Extinguishing Media:NONCOMBUSTIBLE. USE EXTINGUISHING MEDIA APPROPRIATE
    TO SURROUNDING FIRE CONDITIONS.
Fire Fighting Procedures:USE NIOSH/MSHA APPROVED SCBA AND FULL
    PROTECTIVE EQUIPMENT .
Unusual Fire/Explosion Hazard:EMITS TOXIC FUMES UNDER FIRE CONDITIONS.
*  Accidental Release Measures  *
Spill Release Procedures:EVACUATE ARA. WEAR NIOSH/MSHA APPRVD SCBA, RUB
    USE. SWEEP UP, PLACE IN BAG & HOLD FOR WASTE DISPOSAL. AVOID
    RAISING DUST. VENT AREA  & WASH SPILL SITE AFTER MATL PICKUP IS
    COMPLETE.
Neutralizing Agent:NONE SPECIFIED BY MANUFACTURER.
*Handling and Storage  *
Handling and Storage Precautions:KEEP TIGHTLY CLOSED. STORE IN A COOL
    DRY PLACE.
Other Precautions:HIGHLY TOXIC. POSSIBLE TERATOGEN. DO NOT BREATHE
    DUST. DO NOT GET IN EYES, ON SKIN, ON CLOTHING.
*  Physical/Chemical Properties  *
HCC:T3
Appearance and Odor:WHITE CRYSTALLINE POWDER.
*  Stability and Reactivity Data  *
Stability Indicator/Materials to Avoid:YES
STRONG OXIDIZING AGENTS.
Stability Condition to Avoid:NONE SPECIFIED BY MANUFACTURER.
Hazardous Decomposition Products:SULFUR OXIDES, THALLIUM.
*  Disposal Considerations  *
Waste Disposal Methods:CONTACT A LICENSED PROFESSIONAL WASTE DISPOSAL
    SERVICE TO DISPOSE OF THIS MATERIAL. OBSERVE ALL FEDERAL, STATE &
    LOCAL ENVIRONMENTAL REGULATIONS.
